DermOne's GOTTA HAT IT

May is Melanoma Month, and Dallas/Fort Worth celebrities are joining DermOne to fight the most common form of cancer in the U.S. -- skin cancer -- with the inaugural DERMONE’S GOTTA HAT IT benefiting Dallas-based AIM at Melanoma, the largest non-profit international organization focused on melanoma research, education, legislation, and awareness.

Local personalities, fashion designers and trend-setters were given an oversized, floppy sun hat as a blank canvas to express their own uniqueness and (hopefully) cause a bidding war online May 1-31. Proceeds benefit AIM at Melanoma, and DermOne has vowed to match the highest bid (up to $500). DermOne, a national provider of choice in the practice of dermatology, presents these initiatives in an effort to bring awareness and much-needed research funds to melanoma - the deadliest form of skin cancer.

Hats may be viewed at the 10th Annual AIM for the Cure Melanoma Walk on Saturday, May 3, at Bachman Lake in Dallas. The 3.3-mile walk or run is a suggested $50 donation with proceeds benefiting AIM at Melanoma.

DermOne is a leading provider of comprehensive dermatology services through a fast-growing network of neighborhood skin care centers. DermOne offers more providers, more services and more locations, and accepts most major insurance plans. By combining quality, individualized treatment with great service and compassionate care, DermOne strives to ensure the best experience possible for each patient. DermOne has 35 locations across the U.S., with five offices in the DFW Metroplex, located in Arlington, Irving, Mesquite, Waxahachie and Grand Prairie. For more information or to make an appointment, please visit www.DermOne.com.

Based in Dallas, AIM at Melanoma was founded in memory of Charlie Guild, who died of melanoma at the age of 26 and Jim Schlipmann, who died from the disease at 44. AIM at Melanoma is the largest international foundation focused on melanoma research, education, legislation, and awareness. The foundation supports melanoma research efforts by hosting international research forums and is helping to create the first international melanoma tissue bank, widely believed by the oncology community to be a key to major breakthroughs in melanoma research. To learn more, visit www.AIMatMelanoma.org.